Duloxetine Exposure During Pregnancy and the Risk of Offspring Being Born Small for Gestational Age or Prematurely: A Nationwide Danish and Swedish Safety Study.
Mikkel Zöllner AnkarfeldtJanne PetersenJon Trærup AndersenMaria Fernanda Scantamburlo FernandesHu LiStephen Paul MotskoThomas FastEspen Jimenez-SolemPublished in: Drugs - real world outcomes (2022)
Duloxetine exposure during pregnancy is unlikely to increase the risk of small for gestational age. Although not consequently statistically significant across comparisons, a trend towards an increased risk of preterm birth was observed for duloxetine exposed. Therefore, an increased risk of preterm birth cannot be excluded, especially for women exposed to duloxetine throughout pregnancy.